ETEST® Vancomycin (VA) (UDI 03573026620028)Recalls & reported problems
Biomerieux SA · ETEST® is a manual, quantitative technique for determination of antimicrobial susceptibility of non-fastidious Gram-negative and Gram-positive aerobic bacteria and fastidious bacteria · Class 2
Data updated Oct 13, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 0
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 1
Summary
No MAUDE adverse event reports in our data reference this device identifier directly.
1 FDA recall record name this device's identifier, 1 still open.
2 other recalls cover devices cleared under the same FDA submission (K980348); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Recalls naming this device
- Nov 9, 2022Open, Classified
As the temperature and time out of range was exceeded, product performances cannot be guaranteed
Z-0860-2023 · Root cause: Storage · FDA record ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K980348. One submission often covers many models, so check the product and lot details in each record.
- Z-0831-2023 · Nov 9, 2022 · Open, ClassifiedETEST CLINICAL VANCOMYCIN VA 256 US S30, CATALOG 412486
- Z-1525-2017 · Dec 15, 2016 · TerminatedETEST Vancomycin VA 256 FOAM packaging, Product Name: ETEST Vancomycin VA 0.016-256. ETEST is a quantitative technique for determining the antimicrobial susceptibility of Gram-nega
Other Manual antimicrobial susceptibility test systems devices
- ETEST® Imipenem/Relebactam (IPR)Biomerieux SA · Manual antimicrobial susceptibility test systems1 recall4 reports
- ETEST® Amikacin (AK)Biomerieux SA · Manual Antimicrobial Susceptibility Test Systems1 recall2 reports
- ETEST® Tobramycin (TM)Biomerieux SA · Manual Antimicrobial Susceptibility Test Systems1 recall1 report
- ETEST® Ceftriaxone (TX)Biomerieux SA · Manual Antimicrobial Susceptibility Test Systems1 recall0 reports
- ETEST® Levofloxacin (LE)Biomerieux SA · Manual Antimicrobial Susceptibility Test Systems1 recall0 reports
- ETEST® Ceftolozane/Tazobactam (C/T)Biomerieux SA · Manual Antimicrobial Susceptibility Test Systems1 recall0 reports
- ETEST® Minocycline (MC)Biomerieux SA · Manual Antimicrobial Susceptibility Test Systems1 recall0 reports
- ETEST® Ampicillin (AM)Biomerieux SA · Manual Antimicrobial Susceptibility Test Systems1 recall0 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 13, 2026
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 13, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page